Vulvovaginal Candidiasis Withdrawn Phase 2 Trials for Amphotericin B (DB00681)

Back to Vulvovaginal Candidiasis

Also known as: Vulvovaginal Candidiases / Vulvovaginal Candidiasis, Genital / Vulvovaginal Candidiasis (VVC) / Candidiasis, Vulvovaginal / Vulvo-vaginal Candidiasis / Acute candidiasis of vulva and vagina / Candidiasis of vulva and vagina / Candidal vulvovaginitis (disorder) / Vulvovaginal candida

Indication	Status	Phase
DBCOND0032341 (Vulvovaginal Candidiasis)	Withdrawn	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT03167957	Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvovaginal Candidiasis	Treatment	Amphotericin B (DB00681)